Patient Information: The Future of Tumor Ablation Therapies

Article

RFA and other tumor ablation therapies are already widely used to treat liver tumors and to eliminate painful bone tumors. RFA treatment of liver tumors has been approved by the FDA for almost a decade, and some researchers recommend that RFA be the first-line treatment for tumors in that organ.

Researchers are currently studying the use of RFA and other tumor ablation methods for the following areas:
• Kidney
• Lung
• Breast
• Prostate
• Adrenal glands

The National Institutes of Health is conducting studies on RFA for the treatment of liver and kidney tumors and is also testing the efficacy of different equipment.
 

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.